Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Ide-cel induced responses in a majority of heavily pretreated patients with refractory and relapsed myeloma; MRD-negative status was achieved in 26% of treated patients. Almost ...
Publications
View AllAffiliated Researchers
Institution Info
- Type
- education
- Country
- IN
- Publications
- 1
- Citations
- 2,137
External Links
Identifiers
- ROR
- https://ror.org/00cy7e479